Realbotix Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XBOTF research report →
Price Chart
About the company
Realbotix Corp. , headquartered in Toronto, Canada, specializes in the creation of customizable, human-like robots infused with artificial intelligence. Its diverse business operations are segmented into Staking, Metaverse Services, Play-To-Earn Gaming, and Consumer Products.
- CEO
- Andrew Kiguel
- IPO
- 2012
- Employees
- 23
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on XBOTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $20.92M
- P/E
- -4.62
- PEG
- 0.06
- P/S
- 29.35
- P/B
- 2.99
- EV/EBITDA
- -2.41
- Div Yield
- 0.00%
- Gross Margin
- -362.94%
- Op Margin
- -1031.28%
- Net Margin
- -509.47%
- ROE
- -53.00%
- ROIC
- -101.42%
Latest fiscal year · YoY change
- Revenue
- $2.02M+126.0%
- Gross Profit
- $-489,663+94.2%
- Op Income
- $-6,232,625
- Net Income
- $-4,815,719+43.7%
- EPS
- $-0.02+51.4%
- OCF Growth
- -33.8%
- FCF Growth
- -33.8%
- 52W High
- $0.35
- 52W Low
- $0.09
- 50D MA
- $0.17
- 200D MA
- $0.21
- Beta
- 2.89
- RSI (14)
- 19
- Avg Volume
- 202.54K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Realbotix said it is shifting from one-off deployments to a lower-priced direct-to-consumer robot launch while advancing a NASDAQ vehicle transaction and rebuilding both operating businesses for scale.· August 12, 2026
- Management said Realbotix LLC is moving to a direct-to-consumer model with a new robot line planned for September and deliveries targeted for 2027.
- The company plans to lower prices, with the tabletop robot set at $12,000 and the full-size robot in the $55,000 range, plus a $250 deposit model.
- Intima framed RealDoll as an established 30-year brand with over 50,000 customers and more than 120,000 newsletter subscribers.
- The Onco/NASDAQ transaction remains in process; management said the S-4 is being filed this month and the deal values Realbotix LLC at $125 million.
- Management said the school deployment is still proceeding, though privacy reviews are delaying it by weeks, not months.
No quarterly revenue, EPS, or gross margin figures were stated in the call. Andrew Kiguel said the company sold the Tokens.com domain name and still has about $640,000 owed, including another payment due at the end of this month, with completion expected by the end of January 2027. On guidance, management said it does not give formal sales forecasts, but it plans to launch a new robot line in September, move to direct-to-consumer online sales, and begin scaling production in 2027; it also plans to launch situational AI avatars toward the end of this year. The Onco transaction is expected to proceed after the S-4 filing and SEC review, which management said could take two to four months.
Andrew Kiguel emphasized that the company is transitioning from proof-of-concept deployments to a more scalable commercial model, using lower prices, online ordering and a more streamlined customer experience. He said the company is still early, but believes it has validated demand through deployments and inbound interest, and he repeatedly stressed that Realbotix is the only provider of highly realistic human-like robots in America right now. His tone was defensive about media coverage and optimistic about the upcoming product refresh and NASDAQ transaction.
Scott Meyers did not provide a detailed prepared financial review in the transcript, and no revenue, EPS or margin metrics were disclosed on the call. The only specific financial item mentioned was the remaining approximately $640,000 receivable from the Tokens.com domain sale, with a final payment due by the end of January 2027. Management also said the Onco transaction is an all-share deal, values Realbotix LLC at $125 million, and includes a six-month hold on the shares received.
Analysts focused on whether the company can compete on price and whether the merger timing had slipped. Management said the new tabletop robot will be $12,000 with a $250 deposit, the full-size robot will be around $55,000, and Chinese humanoid robots are not allowed to be sold in the U.S., which it argued gives the company protection. On the transaction timing, Andrew said the end date was always the end of November and the main delay is paperwork and audited financials rather than a change in the deal.
The bull case on this call is that Realbotix may be moving from experimental deployments to a repeatable consumer and enterprise model, with lower-priced products and a clearer online sales funnel. Management also pointed to validation from deployments, inbound demand, and the claimed opening created by the U.S. ban on Chinese-made humanoid robots.
The main risks are that current revenue is still low relative to spending, the company is still in a build-out phase, and formal guidance was not provided. The school deployment is delayed by privacy concerns, the Onco transaction remains subject to SEC review, and management acknowledged pressure from media scrutiny and weak share-price performance.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.2%
- Shares Outstanding
- 219.94M
- Float Shares
- 139.10M
Our XBOTF coverage
Recent articles, reports, and earnings notes.
No research on XBOTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XBOTF report →Realbotix Provides Update on Nasdaq Listing Timeline
businesswire.com · Nov 9
Realbotix Rebrands its Humanoid Robot Line to Realbotix Series 1
businesswire.com · Nov 4
Realbotix Relaunched Ask Aria Digital AI Avatar
businesswire.com · Oct 28
Realbotix Launches Echo Humanoid Robot Line
businesswire.com · Oct 26
Realbotix Announces Additional Draw under Bridge Loan from Onconetix
businesswire.com · Oct 23
Realbotix to Exhibit at CES 2027
businesswire.com · Oct 20
Realbotix to Exhibit at Humanoids Summit in Silicon Valley
businesswire.com · Oct 6
Realbotix Appoints David Binkowski as Chief Marketing Officer
businesswire.com · Sep 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.